Santos David A 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Santos David A（CIK 1820066）在 1 家公司共报告 5 笔 SEC Form 4 内部人交易（最近一笔 2026-09-03）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | 卖出 | 874 | $41,515 |
| 2026-06-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | 卖出 | 874 | $26,098 |
| 2026-02-19 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | 买入 | 19,430 | $0 |
| 2026-02-12 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | 卖出 | 3,546 | $122,763 |
| 2026-02-04 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | 卖出 | 5,718 | $205,905 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03